Research programme: glucose metabolism disorder therapeutics - Adocia

Drug Profile

Research programme: glucose metabolism disorder therapeutics - Adocia

Alternative Names: BioChaperone glargine dulaglutide; BioChaperone glargine liraglutide; BioChaperone glucagon

Latest Information Update: 29 Sep 2016

Price : $50

At a glance

  • Originator Adocia
  • Class Antihypoglycaemics; Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists; Glucagon-like peptide 1 modulators; Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Diabetes mellitus; Hypoglycaemia

Most Recent Events

  • 20 Sep 2016 Preclinical trials in Diabetes mellitus in France (SC)
  • 08 Jun 2016 Preclinical trials in Hypoglycaemia in France (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top